corresponding to Human EGFR.
(Peptide available as
This product is a recombinant rabbit monoclonal antibody. Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
An immunizing peptide is available for this antibody as ab190788.
Alternative versions available:
Anti-EGFR (phospho Y1092) antibody (Alexa Fluor® 488) [EP774Y] (ab205827)
Anti-EGFR (phospho Y1092) antibody (Alexa Fluor® 647) [EP774Y] (ab205828)
Our Abpromise guarantee covers the use of ab40815 in the following tested applications.
|IHC-FoFr||Use at an assay dependent concentration. PubMed: 18948956|
|WB||1/500 - 1/5000. Predicted molecular weight: 170 kDa.Can be blocked with EGFR (phospho Y1092) peptide (ab190788).|
|ICC/IF||1/250 - 1/500.|
|IHC-P||1/250 - 1/500.|
Blocking/Diluting buffer 5% NFDM/TBST
Blocking buffer: 5% NFDM/TBST
Dilution buffer: 5% NFDM/TBST
Dot blot analysis of EGFR (pY1092) peptide (Lane 1), SMAD5 (unmodified) peptide labelling EGFR (pY1092) with ab40815 at a dilution of 1/1000. Peroxidase conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody at a dilution of 1/2500.
Blocking and dilution buffer: 5% NFDM/TBST.
Exposure time: 3 minutes.
ab40815 showing positive staining in Cervical carcinoma tissue.